Addressing Challenges in the Management of Generalized Myasthenia Gravis in Specialized Populations: Considerations in Pregnancy and Pediatric Patients

Thursday, October 17, 2024

11:45 AM – 12:45 PM ET simulcast
10:45 AM – 11:45 AM CT
9:45 AM – 10:45 AM MT
8:45 AM – 9:45 AM PT

This activity will be held during the AANEM Annual Meeting. It is not part of the official scientific program of AANEM.

1.0 CME/CNE Credit

Features:

  • Interactive case-based presentation
  • Downloadable whiteboard animation
  • Online personalized poster generation portal

Program Overview

This satellite symposium will seek to increase healthcare provider’s ability to assess therapeutic developments for the management of myasthenia gravis (gMG), including the unique mechanism of FcRn antagonists; evaluate the burden of gMG in pregnant women, as well as current guidelines for care and challenges in management; and summarize best practices in the evaluation, guideline-informed treatment, and consideration of ongoing clinical trials in pediatric patients.

Learning Objectives

  • Assess the therapeutic developments for the management of myasthenia gravis, including the unique mechanism of FcRn antagonists
  • Evaluate the burden of gMG in pregnant women, as well as current guidelines for care and challenges in management
  • Summarize best practices in the evaluation, guideline-informed treatment, and consideration of ongoing clinical trials in pediatric patients with gMG

Target Audience

This activity is designed to meet the educational needs of adult and pediatric neurologists and fellows; advanced care practitioners (eg, NPs, PharmD/RPh, and PAs); and other healthcare professionals who help manage people with gMG.

Joint Accreditation Statement

Joint Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement

Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Nurses (ANCC) Credit Designation

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Disclaimer

Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, both Johnson & Johnson companies.

Release date: October 17, 2024
Expiration date: October 17, 2024
Estimated time to completion: 1 hour